Abstract
The principal initiator of coagulation, Tissue Factor (TF) has now emerged as a critical key player in oncogenic events. TF regulates tumor growth through processes such as anti-apoptosis, tumor angiogenesis and metastasis in various solid tumors such as colorectal carcinoma, glioma and breast tumors. In the last few years it has become clear that these effects are not, or partially, attributable to activation of coagulation. Rather, activation of cellular receptors, by the binary TF:FVIIa complex, the ternary TF:FVIIa:FXa complex or by thrombin, results in intracellular signaling and altered cell behaviour. In this review, the role of TF in complex with FVIIa or FVIIa:FXa as well as the role of the Tissue Factor Pathway Inhibitor in cancer will be discussed.
Keywords: MALIGNANT TUMORS, breast cancer cells, TFPI-2 expression, ANGIOGENESIS, PAR isoforms, MAP kinase
Current Genomics
Title: Emerging Insights in the Role of Tissue Factor in Cancer
Volume: 6 Issue: 6
Author(s): H. H. Versteeg
Affiliation:
Keywords: MALIGNANT TUMORS, breast cancer cells, TFPI-2 expression, ANGIOGENESIS, PAR isoforms, MAP kinase
Abstract: The principal initiator of coagulation, Tissue Factor (TF) has now emerged as a critical key player in oncogenic events. TF regulates tumor growth through processes such as anti-apoptosis, tumor angiogenesis and metastasis in various solid tumors such as colorectal carcinoma, glioma and breast tumors. In the last few years it has become clear that these effects are not, or partially, attributable to activation of coagulation. Rather, activation of cellular receptors, by the binary TF:FVIIa complex, the ternary TF:FVIIa:FXa complex or by thrombin, results in intracellular signaling and altered cell behaviour. In this review, the role of TF in complex with FVIIa or FVIIa:FXa as well as the role of the Tissue Factor Pathway Inhibitor in cancer will be discussed.
Export Options
About this article
Cite this article as:
Versteeg H. H., Emerging Insights in the Role of Tissue Factor in Cancer, Current Genomics 2005; 6 (6) . https://dx.doi.org/10.2174/138920205774482936
DOI https://dx.doi.org/10.2174/138920205774482936 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations
Current Pharmaceutical Design Status Epilepticus in the Immature Rodent Brain Alters the Dynamics of Autophagy
Current Neurovascular Research The Use of Herbal Medicine in Cancer-related Anorexia/ Cachexia Treatment Around the World
Current Pharmaceutical Design Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy
Current Topics in Medicinal Chemistry COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Applications of Lentiviral Vectors for shRNA Delivery and Transgenesis
Current Gene Therapy Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Current Cancer Drug Targets Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery Extracellular ATP and Neurodegeneration
Current Drug Targets - CNS & Neurological Disorders Preparation, Pharmacokinetic and Application of Gold Nanoclusters (AuNCs) in Tumor Treatment
Current Medicinal Chemistry The Targeted-liposome Delivery System of Antitumor Drugs
Current Drug Metabolism Nanocarriers for the Simultaneous Co-Delivery of Therapeutic Genes and Anticancer Drugs
Current Pharmaceutical Biotechnology AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
Current Gene Therapy Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities
Current Medicinal Chemistry Nanodiamonds as a New Horizon for Pharmaceutical and Biomedical Applications
Current Drug Delivery Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature
Current Drug Targets Regulation of Apoptosis and Cell Survival by Resveratrol
Mini-Reviews in Organic Chemistry Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature
Anti-Cancer Agents in Medicinal Chemistry Rational Design of 5-Aminolevulinic Acid Derivatives Aimed at Improving Photodynamic Therapy
Current Medicinal Chemistry - Anti-Cancer Agents